title: The Harvard angiogenesis story.
abstract: I shall discuss the work of researchers at Harvard Medical School who came together in the early 1990s. Scattered across various Harvard-affiliated hospitals and research centers, these individuals were unified by their interest in ocular neovascularization. Together and separately, they investigated models of ocular neovascularization, exploring tumor angiogenesis in eye development and disease.
authors.affiliation: Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA, USA. Electronic address: joan_miller@meei.harvard.edu.
authors.forename: Joan W
authors.initials: JW
authors.lastname: Miller
mesh_terms: D000046:Academic Medical Centers / Q000458:organization & administration*; D035843:Biomedical Research / Q000458:organization & administration*; D020256:Choroidal Neovascularization / Q000503:physiopathology*; D006801:Humans; D008268:Macular Degeneration / Q000503:physiopathology*; D009369:Neoplasms / Q000098:blood supply; D009389:Neovascularization, Pathologic / Q000503:physiopathology; D042461:Vascular Endothelial Growth Factor A / Q000502:physiology
chemical_list: C467484:VEGFA protein, human; D042461:Vascular Endothelial Growth Factor A
keywords: Factor X; Harvard; Macula Society; Paul Henkind Memorial Lecture; age-related macular degeneration (AMD); angiogenesis; choroidal neovascularization (CNV); retinopathy; vascular endothelial growth factor (VEGF)